Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 8 of 191
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Q32 Bio to merge with Homology Medicines

Homology Medicines will issue shares of its common stock to Q32 Bio stockholders as part of the merger deal, in return for cancelling Q32 Bio’s capital stock. Pre-merger

Kesin Pharma receives approval from FDA for LIKMEZ

The first and only FDA-approved ready-to-use oral liquid metronidazole in the country, LIKMEZ is intended for patients who may struggle with dysphagia, difficulty swallowing, or high taste sensitivities.